Biohaven shares climb 7% after signing major SK Biopharmaceuticals licensing deal

Biohaven Ltd. (NYSE:BHVN) shares gained 7% on Wednesday after the biotechnology company announced a strategic global licensing agreement with SK Biopharmaceuticals covering its Kv7 ion channel platform and epilepsy candidate opakalim. The transaction could de…